Skip to main content
. 2022 Dec 14;199(1):67–77. doi: 10.1007/s00066-022-02032-y

Fig. 1.

Fig. 1

Risk of lung complications of breast cancer patients as a function of increasing mean lung dose (MLD). Irrespective of administered combined systemic schedules, the risk of developing clinically apparent radiation pneumonitis (RP; symptomatic grade 2—diamond pattern) and the risk of developing any-grade RP (asymptomatic grade 1 and symptomatic grade 2 together, square pattern) was assessed based on observed incidences in the cohort of 396 patients